AHA 2023: Novel Imaging/Hemodynamic Based Right Ventricular Phenotypes in Patients With Pulmonary Hypertension

Janowski, A., Visovatti, S., Benza, R., Vanderpool, R. “Novel Imaging/Hemodynamic Based Right Ventricular Phenotypes in Patients With Pulmonary Hypertension”. Introduction:  Right ventricular function and ventricular dynamics associate with outcomes in pulmonary hypertension (PH). Measures of RV strain describe ventricular mechanics but are not included in RV function assessments. This study aimed to develop novel RV […]

AHA 2023: Comparison of Pulmonary Arterial Risk Assessment Tools using a harmonized FDA dataset

Fauvel, C., Lin, S., Correa-Jaque, P., Everett, A., Perer, A., Liu, Y., Kanwar, M., Vanderpool, R., Kraisangka, J., Benza, R. “Comparison of Pulmonary Arterial Risk Assessment Tools using a harmonized FDA dataset”. Introduction:  One-year mortality risk for a pulmonary arterial hypertension (PAH) patient is the most substantial. Accordingly, the initial risk stratification should be the […]

AHA 2023: Improvement of Pulmonary Arterial Hypertension risk assessment model using cardiac magnetic resonance imaging variables

Correa-Jaque, P., Lin, Y., Lin, S., Liu, Y., Fauvel, C., Vanderpool, R., Kanwar, M., Kraisangka, J., Perer, A., Everett, A., Alabed, S., Swift, A., Kiely, D., Benza, R. “Improvement of Pulmonary Arterial Hypertension risk assessment model using cardiac magnetic resonance imaging variables”. Introduction PAH is a deadly disease without cure. Formalized risk stratification allows therapeutic […]